Home Menu ↓
Clicking on our sponsor links helps insure continued free access to this website.
Please support our efforts by visiting our sponsors:

 

Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.

Docket No.: 13-854
Certiorari Granted: 3/31/2014
Argued: October 15, 2014
Decided: January 20, 2015

Topics:

Article I, Civil Procedure, Seventh Amendment, antitrust, patent, property rights, trademark

PartyNames: Teva Pharmaceuticals USA, Inc., et al. v. Sandoz, Inc., et al.
Petitioner: Teva Pharmaceuticals USA, Inc., et al.
Respondent: Sandoz, Inc., et al.

Court Below: United States Court of Appeals for the Federal Circuit
Citation: 723 F.3d 1363
Supreme Court Docket

Teva Pharmaceuticals USA, Inc., et al.
v.
Sandoz, Inc., et al.
Background:

Rule 52(a) of the Federal Rules of Civil Procedure provides that in matters tried to a district court, the court's "[f]indings of fact ... must not be set aside unless clearly erroneous

Question Presented:

Whether a district court's factual finding in support of its construction of a patent claim term may be reviewed de novo, as the Federal Circuit requires (and as the panel explicitly did in this case), or only for clear error, as Rule 52(a) requires.

Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
ORAL ARGUMENT

October 15, 2014

Listen to Oral Argument in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
Holding: VACATED AND REMANDED
Vote: 9-0
Opinion By:
Database Connection failed: SQLSTATE[HY000] [1045] Access denied for user 'restauz8_sophi'@'localhost' (using password: YES)